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Background Many human strains of influenza A virus produce
highly pleomorphic virus particles that at the extremes can be
approximated as either spheres of around 100 nm diameter or
filaments of similar cross-section but elongated to lengths of many
microns. The role filamentous virions play in the virus life cycle
remains enigmatic.
Objectives/Methods Here, we set out to define the morphology
and genetics of virus particle shape in equine influenza A virus,
using reverse genetics and microscopy of infected cells.
Results and Conclusions The majority of H3N8 strains tested
were found to produce filamentous virions, as did the prototype
H7N7 A/eq/Prague/56 strain. The exception was the prototype
H3N8 isolate, A/eq/Miami/63. Reassortment of equine influenza
virus M genes from filamentous and non-filamentous strains into
the non-filamentous human virus A/PR/8/34 confirmed that
segment 7 is a major determinant of particle shape. Sequence
analysis identified three M1 amino acid polymorphisms plausibly
associated with determining virion morphology, and the
introduction of these changes into viruses confirmed the
importance of two: S85N and N231D. However, while either
change alone affected filament production, the greatest effect was
seen when the polymorphisms were introduced in conjunction.
Thus, influenza A viruses from equine hosts also produce
filamentous virions, and the major genetic determinants are set by
the M1 protein. However, the precise sequence determinants are
different to those previously identified in human or porcine
viruses.
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Introduction
Influenza A virus (IAV) is a major pathogen of homoeo-
thermic vertebrates, affecting man and a variety of wild and
domesticated mammalian and avian species, with aquatic
birds probably representing the reservoir host.1 The virus
forms enveloped virions containing nine structural proteins
and the eight segments of negative-sense single-stranded
RNA that comprise the genome by budding through the
apical plasma membrane.2 Three viral transmembrane pro-
teins are included in the envelope (haemagglutinin (HA),
neuraminidase and M2 ion channel), linked via their
cytoplasmic domains to an internal layer of a matrix (M1)
protein which in turn interacts with the genomic ribo-
nucleoproteins.
Early studies on the morphology of human strains of virus
established that two types of particle were formed: pleomor-
phic spheres of approximately 100 nm diameter or elongated
forms of the same diameter, but reaching many microns in
length.3,4 Both forms of virus particle are infectious, and
although there are preparation-dependent variations in
particle:infectivity ratios, the overall values for filaments
and spheres are similar.5,6 The majority of low-passage
human IAV strains are filamentous in cell culture, although
this is a trait that can be lost upon prolonged passage in the
laboratory.3,5,7 More recent work has established that the
morphology of virus particles is determined by both viral and
cellular factors. With respect to the virus, segment 7 in
particular, sequence polymorphisms in the M1 gene play a
dominant role.7–10 From the cellular side, epithelial cells tend
to produce more and/or larger filaments than fibroblasts, and
an intact actin cytoskeleton is required for filament but not
for spherical particle formation.11,12 The endocytic traffick-
ing regulator Rab11 and its effector protein Rab11-FIP3 are
also required for filamentous budding.13 However, the
biological significance of the filamentous forms remains
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unclear. Although formation of short filaments in infected
human lung explants has recently been reported,14 convinc-
ing demonstration that filaments are formed in vivo is
lacking, and their significance in pathogenicity in animal
models has not yet been systematically examined. It is also
unclear how widespread the filamentous morphology is
across influenza virus strains from different host species;
filament formation is well established for human IAV and
has been observed for porcine strains.9,15 Here, we show that
the majority of equine IAV strains tested also display a
filamentous phenotype in tissue culture and define amino
acid residues in M1 that control particle shape.
Materials and methods
Cells and viruses
Madin-Darby canine kidney cells (MDCKs) and human
embryonic kidney 293T cells were cultured as described
previously.16 Equine influenza A viruses were sourced from
the World Organization for Animal Health (OIE) reference
collection at the Animal Health Trust, Newmarket, UK
(Table 1). Human H1N1 A/PR/8/34 (PR8) was either the
Cambridge lineage of virus (non-recombinant) or the
MDCK-cell adapted variant of the NIBSC vaccine strain.17
A/Udorn/72 (Udorn: H3N2) was kindly provided by Pro-
fessor Richard Compans.11 The filamentous 7 + 1 reassor-
tant on the PR8 background with segment 7 from Udorn
(PR8 MUd) has been previously described.18 Passage histo-
ries of non-recombinant viruses, where known, are given in
Table 1. Virus stocks were propagated on MDCK cells or in
embryonated hens’ eggs.
Microscopy
For immunofluorescence, cells were fixed with 4% formal-
dehyde in PBS for 20 minute at room temperature and
blocked with repeated washes of PBS containing 1% bovine
serum. Cell surfaces were stained with rabbit polyclonal sera
against whole virus and a fluorescein-conjugated anti-rabbit
IgG secondary antibody (DAKO), with or without staining of
the F-actin cytoskeleton using tetramethylrhodamine-
labelled phalloidin (Sigma) as previously described.12,18
Polyclonal rabbit antiserum was raised against whole A/
equine/Sussex/89 (H3N8) virus, while polyclonal rabbit
antiserum against whole PR8 virus has been previously
described.19 Rabbit antiserum reactive against human H3 HA
(anti-X-31 virus, used to stain Udorn-infected cells) was the
kind gift of Dr David Steinhauer.12 Under the conditions
employed here (unpermeabilized cells), the antivirion sera
primarily stain cell surface HA. Stained cells were visualized
using Leica TCS-NT or Zeiss LSM-710 confocal microscopes.
Projected images of the entire cell surface were generated
from stacked images (each Kalman averaged over four
repetitions) taken at approximately 05 lm intervals through
the depth of the cell using Leica TCS software. Post-capture
Table 1. Equine influenza virus strains used in this study
Virus strain Abbreviation Passage history Accession no. Comments/reference Morphology
A/equine/Prague/56
(H7N7)
Prague/56 Unknown CY130135 Prototype equine H7N7 strain28 Filamentous
A/equine/Miami/63
(H3N8)
Miami/63 Unknown KF049199 Prototype equine H3N8 strain29 Non-filamentous
A/equine/Newmarket/79
(H3N8)
Nkt/79 Unknown KF049200 Pre-divergence equine H330 Filamentous
A/equine/Sussex/89
(H3N8)
Sussex/89 Limited (egg) FJ375237 Pre-divergence equine H331 Filamentous
A/equine/Newmarket/1/93
(H3N8)
Nkt/1/93 Limited (egg) FJ375234 Prototype American lineage strain32 Filamentous
A/equine/Newmarket/2/93
(H3N8)
Nkt/2/93 Limited (egg) FJ375235 Prototype European lineage strain32 Filamentous
A/equine/Philippines/2/97
(H3N8)
Phil/97 Limited (egg) JN850796 American lineage Filamentous
A/equine/Moulton/98
(H3N8)
Moulton/98 Limited (MDCK) JN869240 American lineage Filamentous
A/equine/Newmarket/11/03
(H3N8)
Nkt/11/03 Limited (egg) JN850794 American lineage33 Filamentous
A/equine/Solihull/1/07
(H3N8)
Solihull/07 Limited (egg) JN850795 Florida clade 2 sublineage Filamentous
‘Limited’ indicates fewer than 5 passages on the indicated substrate; ‘unknown’ passage indicates likely extensive passage potentially on more than
one substrate. Accession numbers in bold are for sequences that were generated during the course of this study.
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processing was carried out using Adobe Photoshop. For
negative stain transmission electron microscopy (TEM),
clarified tissue culture supernatants were applied to glow
discharged formvar/carbon-coated copper grids (TAAB),
washed three times in distilled water and stained for
90 seconds in 2% phosphotungstic acid pH 68 before
drying and imaging on a Phillips CM100 TEM. Scanning
electron microscopy (SEM) was carried out as previously
described.12,13
RNA extraction and sequencing
Viral RNA was extracted using the QIAamp viral RNA
extraction kit according to the manufacturer’s instructions.
Viral RNA was reverse-transcribed using 2 lM of segment
7–5′ cRNA (gcgcggtaccGCTCTTCgacccAGCAAAAGCAGG
tagatatttaaag) primer and Superscript II RT enzyme and PCR
amplified using 10 lM each of segment 7–5′ cRNA and
segment 7–5′ vRNA (gcgctctagaGCTCTTCgtattAGTAGAAA
CAAGGtagttttttactcc) primers and native Pfu polymerase
(Stratagene) with 30 cycles of 95°C for 1 minute, 50°C for
15 minute and 72°C for 55 minute. Sequencing was carried
out using BigDyeTM Terminator (Applied Biosystems) and
gene-specific primers (available on request) on an ABI Prism
3100 Genetic Analyser (Applied Biosystems).
Reverse genetics
Segment 7 from equine influenza viruses was amplified using
the segment 7 5′ cRNA and 5′ vRNA primers, and the
resulting cDNA was cloned into a unidirectional reverse
genetics vector pPolI-SapIRib,20 kindly supplied by Professor
Ervin Fodor. These plasmids were then transfected into 293T
cells along with bidirectional plasmids encoding segments 1–
6 and 8 of PR8, kindly supplied by Professor Ron Fouchier.17
Point mutations in M1 were created using site-directed
mutagenesis of the relevant segment 7 plasmids using
mutagenic oligonucleotides (sequences available on request).
The presence of only the desired mutations was confirmed by
sequencing of the plasmids and segment 7 from virus stocks.
Sequence analyses
To generate consensus M1 sequences, the NCBI Influenza
Virus Resource (http://www.ncbi.nlm.nih.gov/genomes/
FLU/FLU.html) was searched for full-length M1 polypeptide
sequences from avian or equine H3N8 viruses, retrieving 746
avian and 131 unique equine sequences (search performed
on 26 July 2013). The multiple alignment tool was then used
to generate a consensus sequence.
Results
To determine whether equine influenza viruses produce
filamentous particles, MDCK cells were infected with a panel
ofH3N8 virus isolates spanning over 40 years (Table 1) as well
as with representative filamentous (Udorn) or non-filamen-
tous (PR8) human virus isolates. As expected, cells infected
with Udorn showed micrometre-long filamentous structures
on their surface that stained brightly for the viral HA
(Figure 1A). In contrast, viral antigen was localized much
more diffusely on the surface of PR8-infected cells, and
filamentous structures were rarely seen. The HA on cells
infected with the prototype H3N8 equine influenza strain,
Miami/63, was similarly diffusely distributed with no obvious
filaments present. Most other equine viruses examined pro-
duced striking filamentous structures that approached 10 lm
in length (e.g.Nkt/79, Sussex/89 and Nkt/11/03 in Figure 1A),
whereas some produced filaments that were around 3–5 lm
long at most (e.g. Phil/97 and Moulton/98 in Figure 1A)
(summarized in Table 1). To test whether the differences in
morphology held true for released virus particles, cell-free
material from Miami/63 and Nkt/11/03 was examined by
negative stain electron microscopy. Miami/63 virions were a
mixture of near-spherical particles around 100 nm in diameter
and more pleomorphic ‘bacilliform’ structures (Figure 1B).
No virus particles with a long axis of greater than approxi-
mately 250 nm were observed. In contrast, Nkt/11/03 virions
were visualized as a mixture of bacilliform particles, highly
elongated and irregular particles and clearly filamentous
virions of consistent diameter but lengths approaching 1 lm.
As no suitable anti-H7 antiserum was available for
immunofluorescence, the morphology of Prague/56 was
determined by SEM. PR8 and PR8 MUd viruses were used
as controls. The surface of PR8-infected cells was profusely
decorated with around 100-nm-diameter spherical struc-
tures, clearly distinguishable from the generally wider and
longer microvilli present on the surface of uninfected cells
(Figure 2A,B). In contrast and as previously observed,13 the
surfaces of PR8 MUd-infected cells were decorated with
bundles of long (in some cases > 20 lm) parallel-sided viral
filaments (panel c). Similar structures, albeit generally less
densely arrayed, were observed on Prague/56-infected cells
(panel d), indicating that it too made filamentous virions.
To determine the role of segment 7 in equine influenza
virus morphology, ‘7 + 1’ reassortants with 7 gene segments
from non-filamentous PR8 and segment 7 of Nkt/11/03, Nkt/
1/93, (examples of filamentous) or Miami/63 (non-filamen-
tous) were generated, and their budding morphology was
determined by immunofluorescence. The PR8 + Miami
reassortant retained the stippled surface HA staining pattern
typical of a non-filamentous virus, whereas the PR8 + Nkt/
11/03 reassortant produced long bundles of filamentous
virions (Figure 3A,B). The filamentous phenotype could
similarly be transferred to PR8 by segment 7 from the Nkt/1/
93 and Sussex/89 strains (data not shown).
Sequencing of segment 7 of the panel of equine influenza
viruses revealed that the predicted amino acid sequence of
the non-filamentous Miami/63 M1 protein differed from the
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consensus equine virus M1 sequence at only three positions:
S85N, K208Q and D231N (Figure 4, boxed). Interestingly,
two of the three differences (S85N, K208Q) were conserved
between Miami/63 and the consensus sequence for avian
H3N8 M1 proteins. Notably, K208Q is in the middle of a
cluster of residues within a predicted a-helix in the
A
B
Fig. 1. Filament formation by H3N8 equine influenza A viruses. (A) MDCK cells infected (or mock infected) with the indicated viruses were fixed at 16 h
p.i., surface stained for viral glycoproteins and examined by confocal microscopy. Images shown are maximum intensity projections of Z-stacks taken
across the depth of the plasma membrane. The mock-infected cells were stained with the anti-equine H3 antiserum. Scale bar: 10 lm. (B) Gallery of virus
particles visualized by negative stain transmission electron microscopy.
(a) (b) (c) (d)
Fig 2. Filament formation by the prototype H7N7 equine influenza A virus. MDCK cells were infected with the indicated viruses at an MOI of 3, fixed at
14 h p.i. and imaged by SEM. Scale bars: 1 lm.
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C-terminal domain of M1 found by previous studies to affect
virion morphology.7–9,21 However, all the equine viruses,
including the non-filamentous Miami/63, possessed the
‘signature’ filamentous amino acid sequences identified for
human H1N1 and H3N2 strains of virus 7,8 at positions 41,
204 and 218. Furthermore, most (with the exception of the
filamentous Prague/56 and Solihull/07 viruses) also matched
the filamentous consensus at position 95 (Figure 4). Simi-
larly, all the H3N8 viruses contained the D30, S207 and A209
residues recently identified as defining filamentous/non-
filamentous morphology in swine-derived 2009 pandemic
viruses.9
To determine which of the M1 polymorphisms seen in
Miami/63 affected particle shape, a set of single amino acid
substitutions was introduced into the PR8 reassortant viruses
altering the Nkt/11/03 sequence to the Miami/63 sequence or
vice versa. Most mutant viruses were readily rescued and
grew to high titres (data not shown), but the D231N change
on the Nkt/11/03 background was difficult to rescue and
grew very poorly, restricting subsequent analyses. When the
mutant viruses were tested for their budding phenotype by
immunofluorescence, K208Q and D231N substitutions did
not have a major effect on the budding of the PR8 + Nkt/11/
03 virus, but an S85N change drastically reduced the
(a) (b)
(b) (d)
(e) (f)
(g) (h)
(i) (j)
Fig. 3. Effect of M1 amino acid polymorphisms on budding morphology. MDCK cells were infected with the indicated viruses at an MOI of < 1. fixed at
16 h p.i and stained for F-actin with Alexa 594-phalloidin (red) and cell surface HA (green) before imaging by confocal microscopy. Maximum intensity
projections of the cell surface are shown.
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formation of long filamentous structures (Figure 3C,E,G).
Conversely, an N85S change was not sufficient to confer an
obvious filamentous phenotype on PR8 + Miami and nor
was the Q208K change (Figure 3D,F). The PR8 + Miami
N231D virus, however, produced small filamentous struc-
tures (Figure 3H). As single mutations had limited effects,
the effects of pairs of changes were tested. A combination of
N85S and Q208K on the PR8 + Miami background
remained non-filamentous (data not shown), whereas a
virus containing N85S and N231D now produced more
obvious bundles of filaments, albeit still shorter than with
PR8 + Nkt/11/03 (Figure 3J). Thus, in equine segment 7, the
identities of M1 amino acids 85 and 231 are crucial
determinants of the ability to form large filamentous
structures on the cell surface.
Immunofluorescent labelling of the cell surface is a conve-
nient way of assessing the ability of a virus to make large
bundles of long filaments, but does not detect shorter
filaments. Accordingly, to assess more subtle phenotypic
changes, the budding morphology of selected viruses was
examined by SEM.Cells infectedwith the parental PR8 + Nkt/
11/03 virus displayed obvious clusters of multiple (often 20 or
Fig 4. Alignment of equine IAV M1 sequences. Predicted amino acid sequences of the indicated M1 polypeptides are aligned to a consensus sequence of
H3N8 equine M1 polypeptides. A consensus sequence for avian H3N8 M1 proteins is also shown. Residues shown to affect budding morphology in
human and/or porcine IAV strains are highlighted by yellow shading. Amino acid differences between the non-filamentous Miami/63 and consensus
sequence are boxed. Cylinders above represent known (solid lines) or predicted (dashed lines) a-helices in M1 from the N-terminal (green), middle (ochre)
and C-terminal (grey) domains of the protein.
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(a) (b) (c)
(d) (e) (f)
Fig. 5. SEM analysis of single M1 polymorphisms of budding phenotype. MDCK cells were infected (or mock infected) with the indicated viruses at an
MOI of 3, fixed at 14 h p.i. and imaged by SEM.
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many more) filamentous virions in parallel array budding
from a discrete foci on the plasma membrane (Figure 5A),
which plausibly represent the large spike-like structures seen
by immunofluorescence. In contrast, PR8 + Miami-infected
cells were decorated with large numbers of small globular
structures approximately 100 nm across with only the occa-
sional small filamentous structure, as expected for a strain that
largely produces spherical particles (Figure 5B). In addition,
the PR8 + Miami-infected cells were largely devoid of the
microvilli seen on the mock-infected cells (Figure 5C). By
SEM, it could be seen that the introduction of the S85N change
into the Nkt/11/03 M1 protein did not totally abolish filament
formation, but drastically reduced their number, such that
large parallel bundles were largely absent (Figure 5D).
Although the reciprocal change (N85S) in PR8 + Miami
clearly increased the number and length of filamentous cell
surface structures compared with the parental virus, the
majority of the budding viruses were still in the form of
spherical particles (Figure 5E). However, introduction of the
N231D change clearly induced the formation of large numbers
of filamentous virions (Figure 5F), to similar levels to the
PR8 + Nkt/11/03 S85N virus. Thus, single amino acid poly-
morphisms at positions 85 and 231 of the equineM1 gene play
dominant, but not exclusive roles in controlling viral budding
morphology.
Discussion
Here, we show that the ability to form filamentous virus
particles in cell culture is a consistent feature of equine
influenza viruses. Filamentous strains included H3N8 viruses
isolated prior to the divergence of the H3 HA into European
and American lineages, isolates from both the latter groups
and from the currently circulating Florida clade 2 sublineage.
We also show that for equine influenza, similarly to other
species of IAV, segment 7 and in particular, the M1 gene
plays a primary role in determining budding morphology.
However, the precise genetic determinants of virion shape
are not the same between human, porcine and equine strains
of virus. By reference to previous data,7–10 the non-filamen-
tous Miami/63 strain might have been predicted to be
filamentous by virtue of the sequence motifs V41, K95, E204,
S207 and A209, with only T218 arguing for a non-filamen-
tous phenotype. Conversely, the filamentous Prague/56
isolate might have been expected to be non-filamentous,
possessing N30, K95, N209 and T218 sequences. Thus,
predicting the budding morphology of a specific IAV strain
from the sequence of its M1 gene may not be straightfor-
ward. The virus species-specific differences defined here
presumably result from the interactions of the highlighted
M1 residues with other sequence polymorphisms encoded
elsewhere in the virus genome. As the filamentous phenotype
was transferable from three equine strains of virus to PR8 by
segment 7, it is likely that these altered protein–protein
interactions are with other regions of M1 and/or the M2
protein, but further work is required to define this.
The single non-filamentous equine IAV we identified was
the prototype H3N8 isolate, Miami/63. This is perhaps
analogous to observations made with human IAV, where the
PR8 and A/WSN/33 isolates are non-filamentous, in contrast
to the majority of more recent isolates.7,8 When tested in the
1940s, 50s and 60s, PR8 was found to be filamentous, and
evidence suggests that the non-filamentous nature of the
currently available passages reflects adaptation to growth in
the laboratory.4,15,22 However, while we do not know the
passage history of our Miami/63 isolate in detail, it is notable
that the slightly older Prague/56 virus (with an unknown but
presumably similar passage history) retained a filamentous
phenotype. There was also no evident correlation between
numbers of egg passage or cell culture-only passage and
filamentous virion production for the more recent H3N8
isolates (Table 1).
An alternative explanation for the non-filamentous nature
of Miami/63 may be its avian virus-like characteristics.
Phylogenetic analyses of internal genes of Prague/56, includ-
ing the matrix genes, suggest that it was long established in
equidae, forming a unique and ancient lineage.23 Equine
influenza viruses of the H3N8 subtype, on the other hand,
are thought to have been introduced into horses directly
from an avian source relatively recently before the prototype
strain Miami/63 was isolated.1,24 Indeed, the consensus
sequences of avian and equine H3N8 M1 genes isolated
from 1963 onwards are very similar, showing only two amino
acid differences (Figure 4). However, Miami/63 matches the
avian consensus rather than the equine at both of these
positions, one of which is the crucial morphology-determin-
ing residue 85. Infection in mammals, including horses, is
usually via the respiratory route, whereas in aquatic avian
species, influenza is an enteric disease.1,25 This suggests the
hypothesis that filamentous budding may be an adaptation
to growth in the respiratory tract, potentially for spread
within and/or between hosts. In this respect, it would be
interesting to examine the budding morphology of A/equine/
Jilin/89 (H3N8). This virus was a direct transmission to
horses from ducks 26 that caused an extensive outbreak in
China, but failed to become established in the equine host.27
The M1 polypeptide of Jilin/89 shares the same substitutions
as Miami/63 at positions 85 and 208. Overall, therefore, the
sequence polymorphisms we identify here provide a knowl-
edge base for future experiments to probe the importance of
filamentous particle formation in IAV pathogenesis.
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